Influence of Cilnidipine on Catecholamine Release in the Perfused Rat Adrenal Medulla

  • Woo, Seong-Chang (Department of Anesthesiology, College of Medicine, Ulsan University (GangNeung Asan Hospital)) ;
  • Baek, Young-Joo (Department of Pharmacology, College of Medicine, Chosun University) ;
  • Lim, Dong-Yoon (Department of Pharmacology, College of Medicine, Chosun University)
  • Published : 2004.10.21

Abstract

The present study was attempted to investigate the effect of cilnidipine (FRC-8635), which is a newly synthesised novel dihydropyridine (DHP) type of organic $Ca^{2+}$ channel blockers, on secretion of catecholamines (CA) evoked by acetylcholine (ACh), high $K^+$, DMPP and McN-A-343 from the isolated perfused rat adrenal gland. Cilnidipine $(1{\sim}10{\mu}M)$ perfused into an adrenal vein for 60 min produced relatively dose- and time-dependent inhibition in CA secretory responses evoked by ACh $(5.32{\times}10^{-3}M),\;DMPP\;(10^{-4}M\;for\;2\;min)$ and McN-A-343 $(10^{-4}M\;for\;2\;min)$. However, lower dose of cilnidipine did not affect CA secretion by high $K^+\;(5.6{\times}10^{-2}\;M)$, higher dose of it reduced greatly CA secretion of high $K^{+}$. Cilnidipine itself did fail to affect basal catecholamine output. In the presence of cilnidipine $(10{\mu}M)$, the CA secretory responses evoked by Bay-K-8644 $(10{\mu}M)$, an activator of L-type $Ca^{2+}$ channels and cyclopiazonic acid $(10{\mu}M)$, an inhibitor of cytoplasmic $Ca^{2+}$-ATPase were also inhibited. Moreover, ${\omega}-conotoxin\;GVIA\;(1{\mu}M)$, a selective blocker of the N-type $Ca^{2+}$ channels, given into the adrenal gland for 60 min, also inhibited time-dependently CA secretory responses evoked by Ach, high $K^+$, DMPP, McN-A-343, Bay-K-8644 and cyclopiazonic acid. Taken together, these results demostrate that cilnidipine inhibits CA secretion evoked by stimulation of cholinergic (both nicotinic and muscarinic) receptors from the isolated perfused rat adrenal gland without affecting the basal release. However, at lower dose, cilnidipine did not affect CA release by membrane depolarization while at larger dose inhibited that. It seems likely that this inhibitory effect of cilnidipine is exerted by blocking both L- and N-type voltage-dependent $Ca^{2+}$ channels (VDCCs) on the rat adrenomedullary chromaffin cells, which is relevant to inhibition of both the $Ca^{2+}$ influx into the adrenal chromaffin cells and intracellular $Ca^{2+}$ release from the cytoplasmic store. It is thought that N-type VDCCs may play an important role in regulation of CA release from the rat adrenal medulla.

Keywords

References

  1. Akaike A, Mine Y, Sasa M, Takaori S. Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. J Pharmacol Expt Ther 255: 333-339, 1990
  2. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide trihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375, 1962
  3. Cheek TR, Burgoyne RD. Effects of activation of muscarinic receptors on intracellular free calcium and secretion in bovine chromaffin cells. Biochim Biophys Acta 846: 167-173, 1985 https://doi.org/10.1016/0167-4889(85)90122-3
  4. Friedman DJ, Duckles SP. Influence of age on control of norepinephrine release: Ca2$^+$ channels and dopamine D2 receptors. Eur J Pharmacol 252:1-9, 1994 https://doi.org/10.1016/0014-2999(94)90568-1
  5. Fujii S, Kameyama K, Hosono M, Hayashi Y, Kitamura K. Effect of cilnidipine, a novel dihydropyridine Ca2$^+$-channel antagonist, on N-type Ca2$^+$ channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 280:1184-1191, 1997
  6. Gandia L, Borges R, Albillos A, Garcia AG. Multiple calcium channel subtypes in isolated rat chromaffin cells. Pflgers Arch 430: 55-63, 1995 https://doi.org/10.1007/BF00373839
  7. Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309: 69-71, 1984 https://doi.org/10.1038/309069a0
  8. Goeger DE, Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on Ca2$^+$ binding and Ca2$^+$ permeability. Biochem Pharmacol 38: 3995- 4003, 1989 https://doi.org/10.1016/0006-2952(89)90679-5
  9. Hammer R, Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31: 2992- 2998, 1982
  10. Harish OE, Kao LS, Raffaniello R, Wakade AR, Shneider AS. Calcium dependence of muscarinic receptor-mediated catecholamine secretion from the perfused adrenal medulla. J Neurochem 48: 1730-1735, 1987 https://doi.org/10.1111/j.1471-4159.1987.tb05730.x
  11. Hirning LD, Fox AP, McCleskey EW, Olivera BM, Thayer SA, Miller RJ, Tsien RW. Dominant role of N-type Ca2$^+$ channels in evoked release of norepinephrine from sympathetic neurons. Science 239:57-61, 1988 https://doi.org/10.1126/science.2447647
  12. Hosono M, Iida H, Ikeda K, Hayashi Y, Dohmoto H, Hashiguchi Y, Yamamoto H, Watanabe N, Yoshimoto R. In vivo and ex vivo Ca-antagonistic effect of 2-methoxyethyl (E)-3-phenyl-2-propen- 1-yl(+/-)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate (FRC-8653), a new dihydropyridine derivative. J Pharmacobiodyn 15: 547-553, 1992 https://doi.org/10.1248/bpb1978.15.547
  13. Hosono M, Fujii S, Himura T, Watanabe K, Hayashi Y, Ohnishi H, Takata Y, Kato H. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn J Pharmacol 69:127-134, 1995 https://doi.org/10.1254/jjp.69.127
  14. Hosono M, Himura T, Watanabe K, Hayashi Y, Ohnishi H, Takata Y, Kato H. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats. Jpn J Pharmacol 69: 119-125, 1995 https://doi.org/10.1254/jjp.69.119
  15. Ikeda K, Hosono M, Iida H, Ohnishi H. Antihypertensive and cardiovascular profiles of a newly synthesized dihydropyridine derivative 2-methoxyethyl (E)030phenyl-2-propen-1-yl($\pm$)-1, 4- dihydro-2, 6-dimethyl-4-(3-nitrophenyl) pyridine-3, 5-dicarboxylate (FRC-8653). Pharmacometrics 44: 433-442, 1992
  16. Inoue M, Kuriyama H. Muscarinic receptor is coupled with a cation channel through a GTP-binding protein in guinea-pig chromaffin cells. J Physiol (Lond) 436: 511-529, 1991 https://doi.org/10.1113/jphysiol.1991.sp018564
  17. Kasai H, Aosaki H, Fukuda J. Presynaptic Ca$^{2+}-antagonist omegaconotoxin irreversibly blocks N-type Ca$^{2+}$ channels in chick sensory neurons. Neurosci Res 4: 228-235, 1987 https://doi.org/10.1016/0168-0102(87)90014-9
  18. Kimura T, Takeuchi A, Satoh S. Inhibition by omega-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine. Eur J Pharmacol 264: 169-175, 1994 https://doi.org/10.1016/0014-2999(94)00459-5
  19. Kimura T, Shimamura T, Satoh S. Effects of pirenzepine and hexamethonium on adrenal catecholamine release in responses to endogenous and exogenous acetylcholine in anesthetized dogs. J Cardiovasc Pharmacol 20: 870-874, 1992 https://doi.org/10.1097/00005344-199212000-00004
  20. Ladona MG, Aunis D, Gandia AG, Garcia AG. Dihydropyridine modulation of the chromaffin cell secretory response. J Neurochemstry 48: 483-490, 1987 https://doi.org/10.1111/j.1471-4159.1987.tb04118.x
  21. Lim DY, Hwang DH. Studies on secretion of catecholamines evoked by DMPP and McN-A-343 in the rat adrenal gland. Korean J Pharmacol 27(1): 53-67, 1991
  22. Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 15(2): 115-125, 1992 https://doi.org/10.1007/BF02974085
  23. Mc Cleskey EW, Fox AP, Feldman D, Cruz LJ, Olivera BM, Tsien RW, Yoshikami D. $\omega$-Conotoxin: direct and persistent block of specific types of Ca2$^+$ channels in neurons but not muscle. Proc Natl Acad Sci USA 84: 4327-4331, 1987 https://doi.org/10.1073/pnas.84.12.4327
  24. Miljanich GP, Ramachandra J. Antagonists of neuronal calcium channels: structure, function and therapeutic implications. Annu Rev Pharmacol Toxicol 35: 707-734, 1995 https://doi.org/10.1146/annurev.pa.35.040195.003423
  25. Misbahuddin M, Oka M. Muscarinic stimulation of guinea pig adrenal chromaffin cells stimulates catecholamine secretion without significant increase in Ca2+ uptake. Neurosci Lett 87: 266-270, 1988 https://doi.org/10.1016/0304-3940(88)90459-4
  26. Nagayama T, Yoshida M, Suzuki-kusaba M, Hisa H, Kimura T, Satoh S. Effect of cilnidipine, a novel dihydropyridine Ca2$^+$ channel blocker, on adrenal catecholamine secretion in anesthetized dogs. J Cardiovasc Pharmacol 32: 479-484, 1998 https://doi.org/10.1097/00005344-199809000-00020
  27. Nakazato Y, Oleshanskly M, Tomita U, Yamada Y. Voltage- independent catecholamine release mediated by the activation of muscarinic receptors in guinea-pig adrenal glands. Br J Pharmacol 93:101-109, 1988 https://doi.org/10.1111/j.1476-5381.1988.tb11410.x
  28. Nakashima M, Kou M, Hashitani H, Chen G, Ono H, Kuriyama H, Suzuki H. Action of FRC-8653 on smooth muscle cells of the rabbit mesenteric artery. Jpn J Pharmacol 57: 51-61, 1991 https://doi.org/10.1254/jjp.57.51
  29. Oike M, Inoue Y, Kitamura K, Kuriyama H. Dual action of FRC8653, a novel dihydropyridine derivative, on the Ca2$^+$ current recorded from the rabbit basilar artery. Circ Res 67: 993-1006, 1990 https://doi.org/10.1161/01.RES.67.4.993
  30. Plummer MR, Logothetis DE, Hess P. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2: 1453-1463, 1989 https://doi.org/10.1016/0896-6273(89)90191-8
  31. Regan LJ, Sah DWY, Bean BP. Ca$^{2+}$ channels in rat central and peripheral neurons: high threshold current resistant to dihydropyridine blockers and $\omega$-conotoxin. Neuron 6: 269-280, 1991 https://doi.org/10.1016/0896-6273(91)90362-4
  32. Saihara S, Sumio M, Hosono N, Hayashi Y, Kitamura Y, Hashimoto S. Effect of FRC-8653 (cilnidipine) on blood pressure changes during the cold pressor test. Jpn Pharmacol Ther 21: 271-276, 1993
  33. Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca$^{2+}$ channels. Nature 303: 535-537, 1982 https://doi.org/10.1038/303535a0
  34. Seidler NW, Jona I, Vegh N, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the Ca$^{2+}$-ATPase of sarcoplasimc reticulum. J Biol Chem 264: 17816-17823, 1989
  35. Shimamura T, Kimura T, Satoh S. Effects of pirenzepine, AF-DX 116 and gallamine on the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: interaction of M1 and M2 receptors with nicotinic receptors. J Pharmacol Exp Ther 257: 369-373, 1991
  36. Suzuki M, Muraki K, Imaizumi Y, Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca$^{2+}$-pump, reduces Ca$^{2+}$--dependent K$^+$ currents in guinea-pig smooth muscle cells. Br J Pharmacol 107: 134-140, 1992 https://doi.org/10.1111/j.1476-5381.1992.tb14475.x
  37. Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd Ed. New York, Speringer-Verlag, p 132, 1987
  38. Tominaga M, Ohya Y, Tsukashima A, et al. Ambulatory blood pressure monitoring in patients with essential hypertension treated with a new calcium antagonist, cilnidipine. Cardiovasc Drugs Ther 11: 43-48,1997 https://doi.org/10.1023/A:1007795722576
  39. Uceda G, Artalejo AR, de la Fuente MT, Lopez MG, Albillos A, Michelena P, Garcia AG, Montiel C. Modulation by L-type Ca$^{2+}$ channels and apamin-sensitive K$^+$ channels of muscarinic responses in cat chromaffin cells. Am J Physiol 266(5 Pt 1): C1432-1439, 1992
  40. Uneyama H, Uchida H, Yoshimoto R, Ueno S, Inoue K, Akaike N. Effects of a novel antihypertensive drug, cilnidipine, on catecholamine secretion from differentiated PC12 cells. Hypertension 31: 1195-1199, 1998 https://doi.org/10.1161/01.HYP.31.5.1195
  41. Uneyama H, Takahara A, Dohmoto H, Yoshimoto R, Inoue K, Akaike N. Blockade of N-type Ca2$^+$ current by cilnidipine (FRC- 8653) in acutely dissociated rat sympathetic neurones. Br J Pharmacol 122: 37-42, 1997 https://doi.org/10.1038/sj.bjp.0701342
  42. Wada Y, Satoh K, Taira N. Cardiovascular profile of Bay-K-8644, a presumed calcium channel activator in the dog. Naunyn- Schmiedebergs Arch Pharmacol 328: 382-387, 1985 https://doi.org/10.1007/BF00692905
  43. Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol 313: 463-480, 1981
  44. Yamada Y, Teraoka H, Nakazato Y, Ohga A. Intracellular Ca$^{2+}$ antagonist TMB-8 blocks catecholamine secretion evoked by caffeine and acetylcholine from perfused cat adrenal glands in the absence of extracellular Ca$^{2+}$. Neurosci Lett 90: 338-342, 1988 https://doi.org/10.1016/0304-3940(88)90212-1
  45. Yoshimoto R, Dohmoto H, Yamada K, Goto A. Prolonged inhibition of vascular contraction and calcium influx by the novel 1,4-dihydropyridine calcium antagonist cinaldipine. Jpn J Pharmacol 56: 225-229, 1991 https://doi.org/10.1254/jjp.56.225